Have heard a handful of anecdotes from Spain (and also now here in NYC) that HIV-infected persons on antiretroviral therapy appear to be less likely to contract Covid-19.

And, of course, as a corollary to this, I am wondering if HIV- persons taking emtricitabine-tenofovir ("PrEP") might also be.

Thirdly, there is the question of, contrary to popular presumption, HIV-infected persons due to unresolved aberrations in cell signaling or other unresolved immune defects might not advance to the most lethal extremes of infection, were they to become infected.

Best resource of data at this point, one might imagine, would be from countries in East Asia that appear to be coming out of (at least the first wave of) this. There are great community based HIV networks I am aware of in Spain, Italy, Germany, UK, others, but I hesitate to ask this of them now. But it seems important for many reasons. Tk u, Mike

More Michael R Barr's questions See All
Similar questions and discussions